References

evrazkar

Евразийский Кардиологический Журнал

Eurasian heart journal

2225-16852305-0748

Евразийская ассоциация кардиологов

10.38109/2225-1685-2022-3-66-72

evrazkar-6340

Research Article

ОБЗОРЫ

REVIEWS

Особенности повреждения миокарда при COVID-19

Features of myocardial damage at COVID-19

https://orcid.org/0000-0002-9452-1776

Хамидов

С. Х.

Hamidov

S. H.

Сардор Хамидович Хамидов, аспирант, ординатор 2-го года, врач-стажёр

2-ой год обучения

инфекционное отделение № 2

199034

Университетская наб., 7/9

197706

улица Борисова, 9А

Санкт-Петербург

spbu.ru

gb40.ru

Sardor H. Hamidov, postgraduate student, 2nd year resident, trainee doctor

2nd year of study

Infectious diseases department No. 2

199034

University nab., 7/9

197706

9A Borisova Street

Saint-Petersburg

spbu.ru

gb40.ru

sardor_4321@mail.ru

https://orcid.org/0000-0001-6115-7923

Обрезан

А. Г.

Obrezan

A. G.

Андрей Григорьевич Обрезан, д. м. н., заведующий кафедры, главный врач

медицинский факультет

кафедра госпитальной терапии

199034

Университетская наб., 7/9

191186

Малая Конюшенная ул., 8

Санкт-Петербург

spbu.ru

sogaz-clinic.ru

Andrey G. Obrezan, MD, Head of the Department, Chief Physician

Faculty of Medicine

Department of Hospital Therapy

199034

University nab., 7/9

191186

Malaya Konyushennaya str., 8

Saint-Petersburg

spbu.ru

sogaz-clinic.ru

https://orcid.org/0000-0002-3775-3124

Лобанова

П. С.

Lobanova

P. S.

Полина Сергеевна Лобанова, врач-инфекционист

195067

Пискарёвский пр., д. 49

Санкт-Петербург

Polina S. Lobanova, infectious diseases doctor

195067

Piskarevsky ave., 49

Saint-Petersburg

https://orcid.org/0000-0001-7831-6126

Азаренко

С. В.

Azarenko

S. V.

Сергей Владимирович Азаренко, главный врач

197706

ул. Пограничников, 2 строение 1

Сестрорецк

Sergey V. Azarenko, Chief Medical Officer

197706

Border Guards str., 2 building 1

Sestroretsk

ФГБОУ ВО «Санкт-Петербургский государственный университет»; СПб ГБУЗ ГБ № 40 Курортного районаРоссияSaint Petersburg State University; City Hospital № 40Russian Federation

ФГБОУ ВО «Санкт-Петербургский государственный университет»; ООО «Международный медицинский центр «СОГАЗ»РоссияSaint Petersburg State University; International Medical Centre “SOGAZ”Russian Federation

СПб ГБУЗ «Клиническая инфекционная больница им. С. П. Боткина»РоссияS. P. Botkin Saint Petersburg Infectious Diseases HospitalRussian Federation

Многопрофильная клиника «Сестрорецкая»РоссияMulti-field Clinic «SestroretskayaRussian Federation

2022

12102022

036672

2022

Хамидов С.Х., Обрезан А.Г., Лобанова П.С., Азаренко С.В.

Hamidov S.H., Obrezan A.G., Lobanova P.S., Azarenko S.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.heartj.asia/jour/article/view/6340

Данная работа посвящена литературному обзору опубликованных статей, в которых исследования сфокусированы на изучении частоты развития, структуры осложнений сердечно-сосудистых заболеваний у пациентов с COVID-19, возникших прижизненно и посмертно: миокардита, миокардиального повреждения, ОИМ, других тромботических событий. В некоторых исследованиях также приведены сравнительные данные COVID-19+ и COVID-19-пациентов, структура осложнений и доля смертности. Результаты изученных материалов свидетельствуют о том, что частота развития кардиологических осложнений и число летальных исходов достоверно чаще встречаются у пациентов с сопутствующими заболеваниями как: артериальная гипертензия, сахарный диабет, ожирение, ХБП, нарушение ритма. Пациенты старше 60 лет находятся в группе повышенного риска тяжёлого течения заболевания, это объясняется тем, что у этих лиц имеются сопутствующие хронические заболевания, которые из-за острого инфекционного процесса декомпенсируются, снижая адаптационные возможности организма, приводят к ухудшению показателей выживаемости.

This work is devoted to a literature review of published articles, where studies are focused on studying the frequency, structure of complications of cardiovascular diseases in patients with COVID-19, that occurred in vivo and post-mortem: myocarditis, myocardial damage, AMI, and other thrombotic events. Some studies also provide comparative data on COVID-19+ and COVID-19- patients, complication patterns, and mortality rates. The results of the studied materials shows that, the frequency of cardiac complications and the number of deaths are significantly more common in patients with concomitant diseases such as arterial hypertension, diabetes mellitus, obesity, CKD, arrhythmias. Patients over 60 years of age are at increased risk of a severe course of the disease, this is due to the fact that these individuals have concomitant chronic diseases that are decompensated due to an acute infectious process, reducing the adaptive capabilities of the organism, and lead to a deterioration in survival rates.

COVID-19миокардитмиокардиальное повреждениеострый инфаркт миокарда

COVID-19myocarditismyocardial injuryacute myocardial infarction

Финансирование статьи не осуществлялось. Статья является частью диссертационной работы

The article was not funded. The article is part of the dissertation work

References1

Bavishi C., Bonow R. O., Trivedi V., Abbott J. D., Messerli F. H., Bhatt D. L. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020; 63 (5): 682-689. https://doi.org/10.1016/j.pcad.2020.05.013

Halushka M. K., Vander Heide R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021; 50: 107300. PMID: 33132119. https://doi.org/10.1016/j.carpath.2020.107300

Благова О. В. Оценка уровня антикардиальных антител у больных с тяжелым и среднетяжелым течением COVID-19 (корреляции с клинической картиной и прогнозом) / О. В. Благова [и др.] // Российский кардиологический журнал. – 2020. – 25 (11): 4054.. [Blagova O. V., Varionchik N. V., Zaydenov V. A., Savina P. O., Sarkisova N. D. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis). Russian Federationn Journal of Cardiology. 2020; 25 (11): 4054. (In Russ.)]. https://doi.org/10.15829/29/1560-4071-2020-4054

Chung, Mina K. et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circulation research vol. 128, 8 (2021): 1214-1236. https://doi.org/10.1161/CIRCRESAHA.121.317997

The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group, Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries, European Heart Journal, 2021; ehab656. https://doi.org/10.1093/eurheartj/ehab656

Linschoten M., Peters S., van Smeden M., et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020; 9 (8): 817-823. PMID: 33222494. https://doi.org/10.1177/2048872620974605

Сережина Е. К. Патофизиологические механизмы и нозологические формы сердечно-сосудистой патологии при COVID-19 / Е. К. Сережина, А. Г. Обрезан // Кардиология. – 2020. – 60 (8): 23-26. [Serezhina E. K., Obrezan A. G. Cardiovascular Pathology in Patients With COVID-19. Kardiologiia. 2020; 60 (8): 23-26. (In Russ.)]. https://doi.org/10.18087/cardio.2020.8.n1215

Pinto D. S. (2021). COVID-19: Myocardial infarction and other coronary artery disease issues. UpToDate. Retrieved April, 2022, from https://www.uptodate.com/contents/covid-19-myocardial-infarction-and-other-coronary-artery-disease-issues#H2554956222

Thygesen K., Alpert J. S., Jaffe A. S., et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72 (18): 2231-2264. https://doi.org/10.1016/j.jacc.2018.08.1038

James L. Januzzi Jr., MD, FACC. Troponin and BNP Use in COVID-19. Mar 18, 2020 Cardiology Magazine. https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19

Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68: 102594. PMID: 34336202. https://doi.org/10.1016/j.amsu.2021.102594

Bonow R. O., Fonarow G. C., O’Gara P. T., Yancy C. W. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020; 5 (7): 751–753. https://doi.org/10.1001/jamacardio.2020.1105

Giustino G., Croft L. B., Stefanini G. G., et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol. 2020; 76 (18): 2043-2055. PMID: 33121710. https://doi.org/10.1016/j.jacc.2020.08.069

De Michieli L., Ola O., Knott J. D., et al. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clinical Chemistry. 2021 Aug; 67 (8): 1080-1089. PMID: 33860295. https://doi.org/10.1093/clinchem/hvab062

Poterucha T. J., Elias P., Jain S. S., et al. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc. 2021; 10 (1): e018476. https://doi.org/10.1161/JAHA.120.018476

Bardají A., Carrasquer A., Sánchez-Giménez R., et al. Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Rev Esp Cardiol (Engl Ed). 2021; 74 (1): 24-32. PMID: 33144126. https://doi.org/10.1016/j.recesp.2020.08.009

Metkus T. S., Sokoll L. J., Barth A. S., et al. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021; 143 (6): 553-565. https://doi.org/10.1161/CIRCULATIONAHA.120.050543

Терещенко С. Н. Диагностика и лечение миокардитов / С. Н. Терещенко [и др.] // Евразийский Кардиологический Журнал. – 2019. – (3): 4-33. [Tereshchenko S. N., Zhirov I. V., Masenko V. P., Narusov O. Yu., Nasonova S. N., Samko A. N., Stukalova O. V., Shariya M. A. DIAGNOSIS AND TREATMENT OF MYOCARDITIDES. Eurasian heart journal. 2019; (3): 4-33. (In Russ.).] https://doi.org/10.38109/2225-1685-2019-3-4-33

Boehmer T. K., Kompaniyets L., Lavery A. M., et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021; 70 (35): 1228-1232. Published 2021 Sep 3. http://dx.doi.org/10.15585/mmwr.mm7035e5

Siripanthong B., Nazarian S., Muser D., et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020; 17 (9): 1463-1471. PMID: 32387246. https://doi.org/10.1016/j.hrthm.2020.05.001

Kociol R. D., Cooper L. T., Fang J. C., et al. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020; 141 (6): e69-e92. https://doi.org/10.1161/CIR.0000000000000745

Inciardi R. M., Lupi L., Zaccone G., et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 819-824. PMID: 32219357. URL: https://pubmed.ncbi.nlm.nih.gov/32219357/

In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han, COVID-19-related myocarditis in a 21-year-old female patient, European Heart Journal, Volume 41, Issue 19, 14 May 2020, Page 1859, https://doi.org/10.1001/jamacardio.2020.1096

Ammirati E., Lupi L., Palazzini M., et al. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis. Circulation. 2022; 145 (15): 1123-1139. PMID: 35404682. https://doi.org/10.1161/CIRCULATIONAHA.121.056817

Eiros R., Barreiro-Pérez M., Martín-García A., et al. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers [published online ahead of print, 2021 Nov 5]. Rev Esp Cardiol (Engl Ed). 2021; S1885-5857(21)00324-8. PMID: 34866030. https://doi.org/10.1016/j.rec.2021.11.001

Rajpal S., Tong M. S., Borchers J., et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021; 6 (1): 116–118. https://doi.org/10.1001/jamacardio.2020.4916

Starekova J., Bluemke D. A., Bradham W. S., et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021; 6 (8): 945-950. https://doi.org/10.1001/jamacardio.2020.7444

Diaz G. A., Parsons G. T., Gering S. K., Meier A. R., Hutchinson I. V., Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021; 326 (12): 1210–1212. https://doi.org/10.1001/jama.2021.13443

Montgomery J., Ryan M., Engler R., et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021; 6 (10): 1202–1206. https://doi.org/10.1001/jamacardio.2021.2833

Witberg G., Barda N., Hoss S., et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021; 385 (23): 2132-2139. https://doi.org/10.1056/NEJMoa2110737

Solomon M. D., McNulty E. J., Rana J. S., et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020; 383 (7): 691-693. https://doi.org/10.1056/NEJMc2015630

Smilowitz N. R., Subashchandran V., Yuriditsky E., Horowitz J. M., Reynolds H. R., Hochman J. S., Berger J. S. Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am Heart J. 2021 Jan; 231: 93-95. PMID: 33181067. https://doi.org/10.1016/j.ahj.2020.10.075

Rashid M., Wu J., Timmis A., et al. Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021; 290 (1): 88-100. https://doi.org/10.1111/joim.13246

Rodriguez-Leor O., Cid Alvarez A. B., Pérez de Prado A., et al. Inhospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroIntervention. 2021; 16 (17): 1426-1433. https://doi.org/10.4244/EIJ-D-20-00935

Saad M., Kennedy K. F., Imran H., et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021; 326 (19): 1940-1952. https://doi.org/10.1001/jama.2021.18890

Manolis A. S., Manolis A. A., Manolis T. A., Melita H. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges. Journal of Cardiovascular Pharmacology and Therapeutics. September 2021: 399-414. https://doi.org/10.1177%2F10742484211011026

Kogan E, Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E., Ergeshov A. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn Pathol. 2022 Feb 17; 17 (1): 31. PMID: 35177093. https://doi.org/10.1186/s13000-022-01207-6

Wallace M., Oliver S. COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion. Presented at the Advisory Committee on Immunization Practices Meeting, Atlanta, June 23–25, 2021 (https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-COVID-Wallace-508.pdf opens in new tab).

Primessnig, U., Pieske, B. M., and Sherif, M. (2021) Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic. ESC Heart Failure, 8: 333-343. https://doi.org/10.1002/ehf2.13075

Watanabe Y., Miyachi H., Mozawa K., et al. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo. Intern Med. 2021; 60 (23): 3693-3700. https://doi.org/10.2169/internalmedicine.8220-21

Paul Jie Wen Tern, Yilin Jiang, Yee How Lau, Wael Almahmeed, S. Gunavathy Selvaraj, Jack Wei Chieh Tan, Wan Azman Wan Ahmad, Jonathan Yap, Khung Keong Yeo, MBBS. Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East. Journal of Asian Pacific Society of Cardiology 2022; 1: e05. https://doi.org/10.15420/japsc.2021.12

Jabagi M. J., Botton J., Bertrand M., et al. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2022; 327 (1): 80–82. https://doi.org/10.1001/jama.2021.21699

Y. N. Aye, A. S. Mai, A. Zhang, O. Z. H. Lim, N. Lin, C. H. Ng, M. Y. Chan, J. Yip, P.-H. Loh, N. W. S. Chew, Acute myocardial infarction and myocarditis following COVID-19 vaccination, QJM: An International Journal of Medicine, 2021; hcab252, https://doi.org/10.1093/qjmed/hcab252

The authors declare that there are no conflicts of interest present.